Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Submitted by
admin
on October 30, 2010 - 12:16pm
Source:
Yahoo/PR NewsWire
News Tags:
hepatitis C
Anadys
ANA598
Headline:
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Do Not Allow Advertisers to Use My Personal information
